Clinical trial
A Randomized, Placebo-controlled Trial of Pre-treatment HPV Vaccination on Outcomes to LEEP Treatment of Cervical High Grade Squamous Intraepithelial Lesions in HIV-infected Women.
NCT01928225 is registered in ClinicalTrials.gov with University of Witwatersrand, South Africa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-controlled Trial of Pre-treatment HPV Vaccination on Outcomes to LEEP Treatment of Cervical High Grade Squamous Intraepithelial Lesions in HIV-infected Women.
- Lead sponsor
- University of Witwatersrand, South Africa
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 2, 2014
- Completion date
- March 1, 2018
- Enrollment
- 180 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cervical high grade squamous intraepithelial lesion